Hyperammonemia inhibits platelet aggregation in rats

Area of Science:

• Biochemistry
• Physiology
• Toxicology

Background:

• Hyperammonemia is a condition characterized by elevated ammonia levels in the blood.
• Platelet dysfunction and altered nitric oxide (NO) metabolism are observed in various pathological states.

Purpose of the Study:

• To investigate the impact of hyperammonemia on ex vivo platelet aggregation and in vivo nitric oxide synthesis in a rat model.
• To explore the role of mitochondrial energy production in hyperammonemia-induced platelet dysfunction.

Main Methods:

• Rats were infused with ammonium acetate to induce hyperammonemia.
• Ex vivo platelet aggregation, platelet cytoplasmic ATP levels, and serum L-arginine were measured.
• Nitrite and nitrate levels (NO by-products) were quantified.
• Mitochondrial energy production was assessed using tetramethylrhodamine ethyl ester (TMRE) fluorescence.
• The effect of nitric oxide synthase inhibition (N-omega-nitro-L-arginine methyl ester) was evaluated.

Main Results:

• Continuous ammonium acetate infusion significantly reduced ex vivo platelet aggregation.
• Platelet cytoplasmic ATP levels and mitochondrial TMRE fluorescence decreased during hyperammonemia.
• Serum L-arginine and nitrite/nitrate levels increased with ammonium infusion.
• Inhibition of nitric oxide synthase attenuated the decrease in platelet ATP and TMRE fluorescence and diminished the anti-aggregatory effect of ammonia.

Conclusions:

• Hyperammonemia accelerates nitric oxide synthesis from L-arginine in rats.
• Increased nitric oxide production likely inhibits ex vivo platelet aggregation by reducing mitochondrial energy production.
• These findings elucidate a mechanism linking hyperammonemia to platelet dysfunction.